Healthcare -
Biotechnology - NASDAQ - US
$ 0.214
5.52 %
$ 14 M
Market Cap
-0.14
P/E
LYRA - DEPRECIATION & AMORTIZATION
Depreciation & Amortization LYRA - Lyra Therapeutics, Inc.
278 K
LAST VALUE
-47.30%
2 YEAR CAGR
27.66%
5 YEAR CAGR
0.00%
10 YEAR CAGR